FMOC-(S)-3-AMINO-3-(2-FLUORO-PHENYL)-PROPIONIC ACID, 97%, 250mg

trans-[4'-Butyl-1,1'-bicyclohexyl]-4-one, 95%, 10g

4-Chloro-3-methylpyridine-2-carbonitrile, 98+%, 1g

1,2,3-Benzotriazole, min 99%, pour la synthèse, 500 g, emballage plastique.

2-Chloro-N-(2,6-dichlorophenyl)-N-phenylacetamide, 95.0%, 10g

(3aR,7aR)-1,3-Bis(2-isopropylphenyl)-3a,4,5,6,7,7a-hexahydro-1H-benzo[d]imidazol-3-ium tetrafluoroborate, 98%, 1g

4-Bromo-1,6-dichloro-2,7-naphthyridine, 98%, 1g

4'-chloro-3-(2,5-dimethylphenyl)propiophenone, 97.0%, 1g

Methyl 2-methyl-6-nitrobenzoate, 95.0%, 5g

2-(8-Chloro-7-fluoronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 25mg

5-BROMO-2-CHLORO-N-METHYLPYRIMIDIN-4-AMINE, 95.0%, 250mg

1-(2,2,2-TRIFLUOROACETAMIDO)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 1g

8-bromoimidazo[1,2-a]pyridin-3-amine, 95.0%, 1g